首页 | 官方网站   微博 | 高级检索  
     

联合去甲氧柔红霉素治疗急性白血病的临床研究
引用本文:李刚,王宝燕,翟欣辉,赵文理,武佐鹏,郑成云,王岐山,邢佩霓,李梅生.联合去甲氧柔红霉素治疗急性白血病的临床研究[J].白血病.淋巴瘤,1998(4).
作者姓名:李刚  王宝燕  翟欣辉  赵文理  武佐鹏  郑成云  王岐山  邢佩霓  李梅生
作者单位:陕西省人民医院,西安医科大学第一附属医院
摘    要:采用以4-去甲氧基柔红霉素(IDA)为主组成的联合化疗方案,治疗33例初发和复发的急性白血病,其中急性淋巴细胞白血病(ALL)7例,急性非淋巴细胞白血病(ANLL)26例。结果:总有效率70%。初治23例ANLL患者,完全缓解(CR)16例,部分缓解(PR)2例,有效率为79%。5例初治ALL患者,4例CR,1例PR。而复发的2例ALL和3例ANLL患者均未缓解。IDA主要副作用表现为骨髓抑制及心脏毒性。认为以IDA组成联合化疗方案治疗初发的急性白血病具有较好的疗效

关 键 词:4-去甲氧基柔红霉素  白血病  急性  化疗

APPLICATION OF THE IDARUBICIN IN THE TREATMENT OF ACUTE LEUKEMIA
Li Gang,Wang Baoyan,Zhai Xinghui,et al Shanxi Provincial Hospital.APPLICATION OF THE IDARUBICIN IN THE TREATMENT OF ACUTE LEUKEMIA[J].Journal of Leukemia & Lymphoma,1998(4).
Authors:Li Gang  Wang Baoyan  Zhai Xinghui  Shanxi Provincial Hospital
Abstract:patients with acute leukemia(AL)were treated with the chemotherapy including idarubicin from Sept. of 1993 to July of 1998. There were 7 patients with acute lymphocytic leukemia(ALL)and 26 patients with acute non lymphocytic leukemia(ANLL).The results showed that the total remission rate was 70%.18 patients achieved complete remission(CR) and partial remission (PR) in 23 initial patients with ANLL. The total remission rate was as high as 79%.4 and 1 in 5 patients with initial ALL got CR and PR respectively. While, in this article there was no effect on 2 patients with relapsed ALL and 3 with relapsed ANLL.The major side effects encountered were marrow suppresion and heart toxicity.
Keywords:Idarubicin  Acute leukemia  Chemotherapy
本文献已被 CNKI 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号